CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS)

$3.62 -0.08 (-2.1622%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 72

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS) News Sources

Trending tickers: Apple, Microsoft, Sandisk, Caterpillar and AstraZeneca

30-01-2026

yahoo.com

AstraZeneca Agrees Up to $18.5 Billion Obesity Drug Deal in China

30-01-2026

yahoo.com

CSPC AstraZeneca Deal Recasts Role In Global Obesity And Diabetes Therapies

01-02-2026

yahoo.com

AZN Obesity Pipeline to Get a Boost From Deal With China's CSPC

02-02-2026

yahoo.com

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Colorectal Cancer of Biparatopic HER2-targeting ADC JSKN003

14-02-2026

yahoo.com

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 and Chemotherapy as Adjuvant Treatment of Breast Cancer

24-03-2026

yahoo.com

Alphamab Oncology Announces the Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 as Neoadjuvant Treatment for Breast Cancer Has Met the Primary Endpoint

01-04-2026

yahoo.com

2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation

22-04-2026

yahoo.com

CSPC’s SYS6051 Trial Approval Adds New Angle To Valuation Story

22-04-2026

yahoo.com

The Evolving EGFR NSCLC Market: 8 Emerging Late-stage Therapies to Watch | DelveInsight

01-06-2026

yahoo.com

CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS) Sentiment Trend

0 25 50 75 100 38 81 86 89 58 71 69 71 65 91 30-01-2026 01-02-2026 02-02-2026 14-02-2026 24-03-2026 01-04-2026 22-04-2026 01-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS) FAQs

toggle

What is the current price of CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS)?

The current price of CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS) is $3.62.


toggle

CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS) absolute price change since previous trading day?

The absolute price change of CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS) since the previous trading day is $-0.08.


toggle

CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS) percentage price change since previous trading day?

The percentage price change of CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS) since the previous trading day is -2.1622%.


toggle

What is the most recent average sentiment score for CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS)?

The most recent average sentiment score for CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS) is 72 out of 100.


toggle

What is the most recent average sentiment for CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS)?

The most recent sentiment for CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS) is .


SEC-8K** Filing Available For CSPC PHARMACEUTICAL-UNSPOADR (CSPCY:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.